Cargando…
Loss of CDKL5 Causes Synaptic GABAergic Defects That Can Be Restored with the Neuroactive Steroid Pregnenolone-Methyl-Ether
CDKL5 deficiency disorder (CDD) is an X-linked neurodevelopmental disorder characterised by early-onset drug-resistant epilepsy and impaired cognitive and motor skills. CDD is caused by mutations in cyclin-dependent kinase-like 5 (CDKL5), which plays a well-known role in regulating excitatory neurot...
Autores principales: | De Rosa, Roberta, Valastro, Serena, Cambria, Clara, Barbiero, Isabella, Puricelli, Carolina, Tramarin, Marco, Randi, Silvia, Bianchi, Massimiliano, Antonucci, Flavia, Kilstrup-Nielsen, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820583/ https://www.ncbi.nlm.nih.gov/pubmed/36613509 http://dx.doi.org/10.3390/ijms24010068 |
Ejemplares similares
-
Therapeutic potential of pregnenolone and pregnenolone methyl ether on depressive and CDKL5 deficiency disorders: Focus on microtubule targeting
por: Barbiero, Isabella, et al.
Publicado: (2021) -
The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo
por: Trovò, L., et al.
Publicado: (2020) -
CDKL5 localizes at the centrosome and midbody and is required for faithful cell division
por: Barbiero, Isabella, et al.
Publicado: (2017) -
Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder?
por: Barbiero, Isabella, et al.
Publicado: (2019) -
GABAergic neuroactive steroids: a new frontier in bipolar disorders?
por: Carta, Mauro Giovanni, et al.
Publicado: (2012)